Scientists recommend that individuals at high risk for bowel cancer should take a daily dose of aspirin.
According to a study published in The Lancet, administering two pills a day for two years led to a 63% reduction in bowel cancer incidence among a group of 861 patients identified as at-risk.
Prof Sir John Burn from Newcastle University, who spearheaded the research, remarked that the evidence is “overwhelmingly strong.”
Experts in the field noted that these findings contribute to an expanding collection of proof indicating that aspirin may play a role in cancer prevention.
The research involved 861 patients diagnosed with Lynch syndrome, a condition that impacts one in every 1,000 individuals.
This syndrome impairs the ability to detect and mend damaged DNA, increasing the likelihood of various cancers, including those of the bowel, womb, and stomach.
